KAREX Stock Overview
An investment holding company, manufactures and sells condoms in Malaysia. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 4/6 |
| Past Performance | 4/6 |
| Financial Health | 5/6 |
| Dividends | 3/6 |
Rewards
Risk Analysis
No risks detected for KAREX from our risk checks.
My Notes
Capture your thoughts, links and company narrative
Karex Berhad Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | RM 0.91 |
| 52 Week High | RM 0.95 |
| 52 Week Low | RM 0.68 |
| Beta | 1.0 |
| 1 Month Change | -3.70% |
| 3 Month Change | 7.06% |
| 1 Year Change | 30.00% |
| 3 Year Change | 114.12% |
| 5 Year Change | 78.43% |
| Change since IPO | 25.36% |
Recent News & Updates
Recent updates
Should You Investigate Karex Berhad (KLSE:KAREX) At RM0.81?
Jan 26
Karex Berhad (KLSE:KAREX) Might Not Be As Mispriced As It Looks
Aug 28Should You Think About Buying Karex Berhad (KLSE:KAREX) Now?
Jan 13Calculating The Intrinsic Value Of Karex Berhad (KLSE:KAREX)
Oct 26Karex Berhad (KLSE:KAREX) Just Released Its Full-Year Earnings: Here's What Analysts Think
Aug 31A Look At The Fair Value Of Karex Berhad (KLSE:KAREX)
Mar 08Karex Berhad (KLSE:KAREX) Is Making Moderate Use Of Debt
Dec 06Update: Karex Berhad (KLSE:KAREX) Stock Gained 95% In The Last Year
Mar 15Is Karex Berhad (KLSE:KAREX) A Risky Investment?
Feb 22How Much Of Karex Berhad (KLSE:KAREX) Do Insiders Own?
Feb 05
Are Poor Financial Prospects Dragging Down Karex Berhad (KLSE:KAREX Stock?
Jan 18Does Karex Berhad's (KLSE:KAREX) Statutory Profit Adequately Reflect Its Underlying Profit?
Dec 31What These Trends Mean At Karex Berhad (KLSE:KAREX)
Dec 13Shareholder Returns
| KAREX | MY Personal Products | MY Market | |
|---|---|---|---|
| 7D | -3.2% | 1.8% | -1.9% |
| 1Y | 30.0% | -15.0% | 7.7% |
Return vs Industry: KAREX exceeded the MY Personal Products industry which returned -15% over the past year.
Return vs Market: KAREX exceeded the MY Market which returned 7.7% over the past year.
Price Volatility
| KAREX volatility | |
|---|---|
| KAREX Average Weekly Movement | 2.9% |
| Personal Products Industry Average Movement | 3.9% |
| Market Average Movement | 4.7% |
| 10% most volatile stocks in MY Market | 10.3% |
| 10% least volatile stocks in MY Market | 2.4% |
Stable Share Price: KAREX has not had significant price volatility in the past 3 months compared to the MY market.
Volatility Over Time: KAREX's weekly volatility (3%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1988 | 3,149 | Miah Goh | www.karex.com.my |
Karex Berhad, an investment holding company, manufactures and sells condoms in Malaysia. The company offers personal lubricants; probe covers; and catheters for transurethral drainage of the urinary bladder, as well as gloves. It also offers hand sanitizer and pre-vulcanised latex products.
Karex Berhad Fundamentals Summary
| KAREX fundamental statistics | |
|---|---|
| Market cap | RM 958.65m |
| Earnings (TTM) | RM 19.58m |
| Revenue (TTM) | RM 513.30m |
49.0x
P/E Ratio1.9x
P/S RatioIs KAREX overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| KAREX income statement (TTM) | |
|---|---|
| Revenue | RM 513.30m |
| Cost of Revenue | RM 338.84m |
| Gross Profit | RM 174.46m |
| Other Expenses | RM 154.88m |
| Earnings | RM 19.58m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.019 |
| Gross Margin | 33.99% |
| Net Profit Margin | 3.82% |
| Debt/Equity Ratio | 25.5% |
How did KAREX perform over the long term?
See historical performance and comparisonDividends
1.6%
Current Dividend Yield54%
Payout RatioCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/01/11 11:30 |
| End of Day Share Price | 2025/01/10 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2024/06/30 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Karex Berhad is covered by 12 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Aaron Jen Kee | Affin Hwang Investment Bank |
| Lik Hsin Aw | CGS International |
| Megat Fais | Citigroup Inc |